47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
41.10.Z - Construction work related to the construction of residential and non-residential buildings
47.74.Z - Retail sale of medical and orthopedic products
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.20.Z - Rental and management of own or leased real estate
78.30.Z - Employment activities
82.99.Z - Other business support activities, not elsewhere classified
86.90.E - Healthcare
45.11.Z
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 4 | 8,1 | 8,9 | 9,8 |
EBITDA | 4,3 | 8,3 | 9,1 | 9,1 |
Short time liabilities | 2,5 | 4,1 | 4,4 | 7,1 |
Equity capital | 11,4 | 19,2 | 26,6 | 38,3 |
Operating profit (EBIT) | 4,1 | 8,1 | 8,9 | 9,7 |
Assets | 17,5 | 26,1 | 33 | 26,3 |
Net profit (loss) | 3,3 | 8,1 | 8,8 | 8,3 |
Cash | 0,7 | 8,5 | 12,9 | 51,5 |
Net income from sale | 45,9 | 53,8 | 55,8 | 3,6 |
Liabilities and provisions for liabilities | 6,1 | 6,9 | 6,4 | -7 |
Working assets | 5,1 | 15,2 | 19,7 | 30 |
Depreciation | 0,2 | 0,2 | 0,2 | -15,1 |
% | % | % | p.p. | |
Profitability of capital | 28,6 | 42,2 | 33,1 | -9,1 |
Equity capital to total assets | 65 | 73,6 | 80,6 | 7 |
Gross profit margin | 8,8 | 15,1 | 16 | 0,9 |
EBITDA Margin | 9,3 | 15,5 | 16,3 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 20 | 28 | 29 | 1 |
Current financial liquidity indicator | 1.989047884941101 | 3.640714406967163 | 4.4173736572265625 | 0,8 |
Net dept to EBITDA | 0.7884579300880432 | -0.6269878149032593 | -1.1244515180587769 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane